Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
NCT ID: NCT01685970
Last Updated: 2012-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
200 participants
INTERVENTIONAL
2012-09-30
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aimed to evaluate the efficacy and tolerability of bowel preparation protocols with same-day 2 sachets picosulfate compared to conventional high volume (4L) split-dose for afternoon colonoscopy.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators aimed to evaluate the efficacy and tolerability of bowel preparation protocols with same-day 2 sachets picosulfate compared to conventional high volume (4L) split-dose for afternoon colonoscopy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High volume Split-dose PEG
Patients who are scheduled afternoon colonoscopy ingest high volume split-dose PEG for bowel preparation
High volume split-dose PEG
High volume split-dose PEG 2L/2L 2 times before the day and at the day of colonoscopy
2 sachets of picosulfate
Patients who are scheduled afternoon colonoscopy ingest 2 sachets of picosulfate at the day of colonoscopy.
2 sachets of picosulfate
2 sachets of picosulfate 2 times for bowel preparation at the day of colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High volume split-dose PEG
High volume split-dose PEG 2L/2L 2 times before the day and at the day of colonoscopy
2 sachets of picosulfate
2 sachets of picosulfate 2 times for bowel preparation at the day of colonoscopy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* breast feeding,
* prior history of surgical large bowel resection,
* severe medical condition such as severe cardiac,
* hepatic, or
* renal failure (creatinine ≥ 3.0 mg/dL (normal 0.8-1.4 mg/dL)),
* significant gastric paresis or gastric outlet obstruction or ileus,
* known or suspected bowel obstruction or perforation,
* drug addiction or major psychiatric illness,
* allergy to PEG and refusal to participate in the study
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inje University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eun Hee Seo, MD
Comparison of using the same-day 2 sachets picosulfate versus high volume PEG bowel preparation for aternoon colonoscopy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tae Oh Kim, Ph D
Role: STUDY_DIRECTOR
Haeundae Paik Hospital, Inje University College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haeundae Paik Hospital, Inje University College of Medicine
Busan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eun Hee Seo, MD
Role: primary
Tae Oh Kim, Ph D
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HGI-2012-09
Identifier Type: -
Identifier Source: org_study_id